6th Gene Therapy Analytical Development and CMC Summit
Evvnt Promotion / evvnt
30.10.2024 - 01.11.2024 The Westin Copley Place, 10 Huntington Ave, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2481285-2?pid=4832
Ms. Karina Bikerniece
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
